Psychedelic Drugs Market Projected to Reach $6,859.95 Million by 2027

The psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD 6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugsContinue reading “Psychedelic Drugs Market Projected to Reach $6,859.95 Million by 2027”

Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic

Trials are already underway testing the use of psychedelics such as psilocybin, LSD, ketamine, ecstasy and other currently scheduled drugs to treat a mental health epidemic predicted to hit after the lockdown is over. New research in the USA is also pointing to antidepressants such as Prozac made by Eli Lilly and Company (NYSE:LLY) as a potential redirected treatment against the cause ofContinue reading “Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic”